Risk of cardiac ‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database

ConclusionsWith a median follow ‐up of 25 months, no significant differences were found in cardiac‐related mortality between the PORT and Non‐PORT groups in stage IIIA‐N2 NSCLC patients.

Source: Thoracic Cancer - March 17, 2021 Category: Cancer & Oncology Authors: Xin Sun, Yu Men, Jianyang Wang, Yongxing Bao, Xu Yang, Maoyuan Zhao, Shuang Sun, Meng Yuan, Zeliang Ma, Zhouguang Hui Tags: ORIGINAL ARTICLE Source Type: research